Conditions: Head and Neck Neoplasms
Keywords: recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence
Allocation: NON_RANDOMIZED | Intervention model: 
Enrollment: 69
Healthy volunteers: no

Brief summary:
This study will investigate the safety and efficacy of oral PF-00299804 in patients who have not yet undergone any other drug treatment for recurrent and/ or metastatic head and neck squamous cell cancer.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: PF-00299804
Intervention descriptions: intervention 1: 45 mg by continuous oral dosing

Protocol document: